Advanced in Multiple Sclerosis (MS)

Eric Manchon

Fondation Rothschild
Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Multiple Sclerosis (MS)
Fondation Rothschild
Paris, FR 
OverviewLocationsClinical Research

Overview

Eric Manchon practices in Paris, France. Mr. Manchon is rated as an Advanced expert by MediFind in the treatment of Multiple Sclerosis (MS). His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, Transverse Myelitis, and Thrombectomy.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles and participated in 3 clinical trials in the study of Multiple Sclerosis (MS).

Gender
Male

Locations

Fondation Rothschild
Paris, France
Other Locations
Gonesse, France
Toulouse, France
Dijon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Enrollment Status: Recruiting
Publish Date: October 24, 2023
Intervention Type: Other, Drug
Study Drug: Disease Modifying Therapies
Study Phase: Phase 3
Validation Study of the French Adaptation of the MSWDQ-23 Questionnaire, a Tool Assessing the Work Difficulties of Patients With Multiple Sclerosis.
Validation Study of the French Adaptation of the MSWDQ-23 Questionnaire, a Tool Assessing the Work Difficulties of Patients With Multiple Sclerosis.
Enrollment Status: Completed
Publish Date: February 05, 2024
Intervention Type: Other
A 2-Year Prospective Study to Assess Health-related Quality of Life In Subjects With Highly-Active Relapsing Multiple Sclerosis Treated With Mavenclad® (CLARIFY MS)
A 2-Year Prospective Study to Assess Health-related Quality of Life In Subjects With Highly-Active Relapsing Multiple Sclerosis Treated With Mavenclad® (CLARIFY MS)
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Mavenclad®
Study Phase: Phase 4
View 2 Less Clinical Trial

19 Total Publications

Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion.
Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion.
Journal: Neurology
Published: November 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Manchon's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile